MYO9A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.873000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.397000E-01
Normal-vs-Stage2
3.146600E-01
Normal-vs-Stage3
1.741800E-01
Normal-vs-Stage4
8.891600E-01
Stage1-vs-Stage2
4.358200E-01
Stage1-vs-Stage3
4.012200E-02
Stage1-vs-Stage4
5.745400E-01
Stage2-vs-Stage3
3.55782070471378E-12
Stage2-vs-Stage4
1.625230E-01
Stage3-vs-Stage4
5.364300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.776800E-01
Normal-vs-AfricanAmerican
9.270600E-01
Normal-vs-Asian
1.332980E-01
Caucasian-vs-AfricanAmerican
1.876560E-01
Caucasian-vs-Asian
1.860790E-01
AfricanAmerican-vs-Asian
8.929600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.415800E-01
Normal-vs-Female
3.629800E-01
Male-vs-Female
5.743400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.613200E-01
Normal-vs-Age(41-60Yrs)
5.714600E-01
Normal-vs-Age(61-80Yrs)
2.137200E-01
Normal-vs-Age(81-100Yrs)
6.141500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.998800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.436400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.416240E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.170200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.394400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.992440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.156100E-02
Normal-vs-Daily Drinker
1.323630E-01
Normal-vs-Weekly Drinker
1.632450E-01
Normal-vs-Occasional Drinker
3.074400E-01
Normal-vs-Social Drinker
8.520000E-01
Non Drinker-vs-Daily Drinker
9.477800E-01
Non Drinker-vs-Weekly Drinker
8.231000E-01
Non Drinker-vs-Occasional Drinker
2.476400E-01
Non Drinker-vs-Social Drinker
1.566970E-01
Daily Drinker-vs-Weekly Drinker
8.081800E-01
Daily Drinker-vs-Occasional Drinker
2.952000E-01
Daily Drinker-vs-Social Drinker
1.608230E-01
Weekly Drinker-vs-Occasional Drinker
4.594800E-01
Weekly Drinker-vs-Social Drinker
2.163200E-01
Occasional Drinker-vs-Social Drinker
4.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.029800E-01
Normal-vs-Grade 2
7.902400E-02
Normal-vs-Grade 3
6.186300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.089200E-01
Grade 1-vs-Grade 3
2.512000E-01
Grade 1-vs-Grade 4
2.029800E-01
Grade 2-vs-Grade 3
5.536600E-01
Grade 2-vs-Grade 4
7.902400E-02
Grade 3-vs-Grade 4
6.186300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.122000E-01
Normal-vs-NonDiabetic
2.060800E-01
Diabetic-vs-NonDiabetic
8.423800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.571200E-01
Normal-vs-NoPancreatitis
2.167800E-01
Pancreatitis-vs-NoPancreatitis
5.335200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.078200E-01
Normal-vs-N1
3.371200E-01
N0-vs-N1
3.273200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.575200E-01
Normal-vs-TP53-NonMutant
5.052000E-01
TP53-Mutant-vs-TP53-NonMutant
9.940400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
